Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease

Makoto Saito1, Faisal Khan2, Ted Stoklosa2

  • 1Menzies Institute for Medical Research, Hobart, Australia.

Insights

Left ventricular strain and its changes predict major adverse cardiac events in hypertensive heart disease. A new risk score including strain improves MACE prediction.

Area of Science:

  • Cardiology
  • Echocardiography
  • Hypertensive Heart Disease

Background:

  • Hypertensive heart disease is linked to adverse cardiac events, often associated with abnormal left ventricular (LV) morphology.
  • The role of subclinical LV dysfunction, specifically LV strain, in predicting these events remains unclear.

Purpose of the Study:

  • To investigate the association of left ventricular (LV) strain and its serial changes with major adverse cardiac events (MACE) in hypertensive heart disease.
  • To determine if LV strain provides predictive value independent of and incremental to clinical and LV geometric parameters.

Main Methods:

  • Retrospective study of 388 asymptomatic hypertensive patients with abnormal LV geometry.
  • Global longitudinal strain (GLS) measured by speckle tracking; patients followed for MACE over a median of 4 years.
  • Cox proportional hazards model used to assess associations; risk score developed and validated.

Main Results:

  • Major adverse cardiac events (MACE) were associated with concentric hypertrophy and impaired GLS (p < 0.01).
  • GLS association with MACE was independent of and incremental to clinical factors and hypertrophy.
  • Deterioration in GLS correlated with MACE; a risk score (age >70, AF, hypertrophy, baseline GLS) showed good discrimination (C-statistic 0.71).

Conclusions:

  • Global longitudinal strain (GLS) and its deterioration are significant predictors of MACE in asymptomatic hypertensive heart disease.
  • A risk score incorporating GLS is valuable for predicting MACE in this patient population.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
735
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
885
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K